Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
News|Articles|June 2, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-06-07-2016
- Volume 11
- Issue 6
Raman Microscope Measures Uneven Surfaces
Live Track focus tracking technology on the Renishaw inVia Qontor Raman microscope enables the analysis of samples with uneven, curved, or rough surfaces.
Renishaw has added Live Track focus tracking technology to the inVia Qontor Raman microscope, enabling the analysis of samples with uneven, curved, or rough surfaces. The microscope allows users to acquire accurate and reproducible spectra from samples with extensive topographic variations.
The focus is maintained in real time during data collection and white light video viewing, removing the need for manual focusing, pre-scanning, or sample preparation, the company reports.
The LiveTrack technology provides continuous feedback to the sample stage, which adjusts to follow the height of the sample. This ensures the laser maintains focus during data collection and when manually moving the sample during white light video viewing. Optimum focus is maintained across uneven, sloping, or dynamic samples, limited only by the maximum travel of the stage.
Source:
Articles in this issue
over 10 years ago
Slow Serialization Efforts May Delay Business Benefitsover 10 years ago
Scientific Approach Ensures Accurate Weighing Resultsover 10 years ago
Ensuring Biologic API Uniformityover 10 years ago
Biomanufacturing Outsourcing Budgets Grow, Slowlyover 10 years ago
Novasep Starts Kilogram-Scale Batch Production at US Facilityover 10 years ago
FUJIFILM Opens New Laboratory in North Carolinaover 10 years ago
Catalent Opens Korean Sales Officeover 10 years ago
Juniper Pharma Services Expands Topicals Capacityover 10 years ago
ED-XRF Spectrometers Offer Rapid Elemental Analysisover 10 years ago
Particle Analyzer Based on Light ScatteringRelated to this article
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
Can Continuous Tableting End Scale-Up for Complex Oral Drugs?
3
Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap
4
CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care
5